Ananth Kadambi
personal info
Ananth Kadambi is Vice President of Real World Evidence & Modeling Solutions within Certara’s Evidence and Access group, part of Certara Drug Development Solutions (CDDS). Dr. Kadambi has more than 20 years of experience in pharmaceutical consulting across a variety of disciplines, including quantitative systems pharmacology modeling, health economic modeling, systematic literature reviews, indirect treatment comparisons, and complex statistical analyses of clinical and real-world databases required to support regulatory, payer and HTA submissions worldwide.
Most recently, Dr. Kadambi has led teams conducting real world evidence studies, literature review, and cost effectiveness modeling that were used to support worldwide HTA submissions to the National Institute for Health and Care Excellence (NICE) in the UK, the Canadian Agency for Drugs and Technologies in Health (CADTH), Gemeinsamer Bundesauschuss (G-BA) in Germany, Haute Autorite de Sante in France, the TLV in Sweden, and the Academy of Managed Care Pharmacy (AMCP) in USA. Prior to joining Certara, Dr. Kadambi was senior director at Evidera, senior vice president, PhysioPD ™at Rosa & Co., LLC, and vice president of R&D at Entelos Inc. In these roles, he held wide ranging executive management and program leadership responsibilities. Dr. Kadambi’s scientific expertise includes inflammation, cardiovascular disease, and cancer biology. Dr. Kadambi completed his PhD in biomedical engineering at the University of Virginia, Charlottesville, Virginia. He has co-authored published peer-reviewed manuscripts in life science, modeling, and health economic journals including BMC Cancer Clinical Therapeutics, Postgraduate Medicine, Science, Blood , and Cancer Research.